DTL
RLAY icon

Dynamic Technology Lab’s Relay Therapeutics RLAY Stock Holding History

Dynamic Technology Lab’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,658
Closed -$276K – 1131
2025
Q4 		$276K Sell
32,658
-21,495
-40% -$153K 0.06% 517
2025
Q3 		$283K Buy
54,153
+37,218
+220% +$142K 0.05% 574
2025
Q2 		$59K Sell
16,935
-3,132
-16% -$9.32K 0.01% 868
2025
Q1 		$53K Buy
+20,067
New +$78.6K 0.01% 929
2024
Q2 		– Sell
-44,632
Closed -$370K – 1311
2024
Q1 		$370K Buy
44,632
+23,869
+115% +$233K 0.04% 705
2023
Q4 		$228K Buy
20,763
+6,125
+42% +$51.7K 0.02% 846
2023
Q3 		$123K Buy
+14,638
New +$157K 0.01% 846
2022
Q3 		– Sell
-11,930
Closed -$200K – 1458
2022
Q2 		$200K Buy
+11,930
New +$256K 0.02% 916
2021
Q4 		– Sell
-11,340
Closed -$358K – 1439
2021
Q3 		$358K Buy
+11,340
New +$382K 0.04% 679

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Dynamic Technology Lab's RLAY Position: Q1 2026 in Review

Dynamic Technology Lab sold out of Relay Therapeutics (RLAY) in Q1 2026, closing a stake of 32,658 shares — an estimated $276K sold.

Dynamic Technology Lab first reported a position in RLAY in Q3 2021 and held it in 9 quarters. The position peaked at $370K in Q1 2024. 244 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Dynamic Technology Lab reported no remaining Relay Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 32,658 Relay Therapeutics shares in Q1 2026, an estimated $276K.
  • Dynamic Technology Lab first reported a position in Relay Therapeutics in Q3 2021 and held it in 9 quarters.
  • Dynamic Technology Lab's Relay Therapeutics position peaked at $370K in Q1 2024.
  • 244 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.